1. Home
  2. INBS vs SNOA Comparison

INBS vs SNOA Comparison

Compare INBS & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

N/A

Current Price

$1.69

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

N/A

Current Price

$1.15

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INBS
SNOA
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.1M
IPO Year
2019
2006

Fundamental Metrics

Financial Performance
Metric
INBS
SNOA
Price
$1.69
$1.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.9K
★ 36.7K
Earning Date
11-11-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.26
EPS
N/A
★ N/A
Revenue
$1,980,484.00
★ $19,529,000.00
Revenue This Year
$44.72
$22.44
Revenue Next Year
$44.26
$12.73
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 36.68
52 Week Low
$0.54
$0.85
52 Week High
$24.90
$4.06

Technical Indicators

Market Signals
Indicator
INBS
SNOA
Relative Strength Index (RSI) 49.82 42.04
Support Level $1.52 $1.03
Resistance Level $1.92 $1.29
Average True Range (ATR) 0.10 0.07
MACD 0.04 -0.00
Stochastic Oscillator 80.95 21.05

Price Performance

Historical Comparison
INBS
SNOA

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: